NASDAQ: PSTV
Plus Therapeutics Inc Stock Ownership - Who owns Plus Therapeutics?

Insider buying vs selling

Have Plus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew John Hugh Macintyre SimsChief Financial Officer2025-11-0420,000$0.51
$10.20kBuy
Robert P. LenkDirector2025-08-22110,000$0.49
$53.79kBuy

1 of 1

PSTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PSTV insiders and whales buy or sell their stock.

PSTV Shareholders

What type of owners hold Plus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kian Thiam Lim107.84%7,400,000$45.44MInsider
Bank Sa Swissquote77.65%5,328,229$32.72MInsider
Ag Postfinance66.21%4,543,086$27.89MInsider
Olympus Corp58.48%4,013,043$24.64MInsider
Vanguard Group Inc33.22%2,279,414$14.00MInstitution
L1 Global Manager Pty Ltd33.19%2,277,703$13.99MInstitution
Blackrock Inc25.89%1,776,372$10.91MInstitution
Geode Capital Management LLC20.44%1,402,794$8.61MInstitution
Jane Street Group LLC14.92%1,023,905$6.29MInstitution
Ubs Group Ag12.76%875,846$5.38MInstitution

1 of 3

PSTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PSTV32.20%67.80%Net Buying
MREO7.77%4.17%
LITS22.74%50.97%Net Selling
INMB19.12%27.83%
ATRA15.07%84.93%Net BuyingNet Selling

Plus Therapeutics Stock Ownership FAQ

Who owns Plus Therapeutics?

Plus Therapeutics (NASDAQ: PSTV) is owned by 168.37% institutional shareholders, 354.55% Plus Therapeutics insiders, and 0.00% retail investors. Kian Thiam Lim is the largest individual Plus Therapeutics shareholder, owning 7.40M shares representing 107.84% of the company. Kian Thiam Lim's Plus Therapeutics shares are currently valued at $45.07M.

If you're new to stock investing, here's how to buy Plus Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.